This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Primary Care/ Family Medicine  • Substance Abuse/ Alcoholism  • Alert me on articles by topic

Mike Mitka

JAMA. 2003;290:735-736.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Chicago—Office-based physicians in general practice are being called to treat the "new" heroin addict—young professionals who dwell in tree-lined suburbs rather than disadvantaged youth scrabbling in the asphalt jungle.

While heroin traditionally has been associated with inner-city drug addicts, today's user is more and more likely to be an employed young professional living in the suburbs, said John F. Schneider, MD, PhD, immediate past president of the Illinois State Medical Society.

Schneider was speaking here in July during a Substance Abuse and Mental Health Services Administration (SAMHSA) physician training session focusing on buprenorphine—the first opiate addiction treatment drug that can be prescribed by physicians outside licensed clinics. Chicago is 1 of 15 cities where SAMHSA is holding 2-hour training sessions this year.

Currently, only 48 physicians in Illinois are authorized to prescribe buprenorphine.

The changing socioeconomic status of those dependent on opiates means treatment needs to be . . . [Full Text of this Article]